In the early hours of the 16th century, a child in a small European village would not simply cough but would emit a sound so violent and high-pitched that it seemed to tear the air itself. This was the first recorded description of whooping cough, a disease that would haunt humanity for centuries before its cause was ever understood. The illness begins deceptively, mimicking a common cold with a runny nose and mild fever, lulling families into a false sense of security. Yet within days, the cough transforms into uncontrollable paroxysms that can last for three months, earning the disease its grim nickname, the 100-day cough. During these violent fits, the victim gasps for air, producing a high-pitched whoop that signals the end of the breath, often followed by vomiting or even fainting. The physical toll is severe, capable of causing rib fractures, hernias, and subconjunctival hemorrhages, while infants under one year old may suffer from apnea, stopping breathing entirely without ever producing the characteristic sound. This disease, caused by the bacterium Bordetella pertussis, remains one of the most contagious and dangerous respiratory infections known to medicine, capable of killing nearly 0.5% of infected infants and leaving survivors with lasting complications.
The Silent Killer In The Air
The bacterium Bordetella pertussis is a microscopic assassin that thrives on the very air its victims breathe. Discovered in 1906 by Jules Bordet and Octave Gengou, this pathogen is an airborne specialist that spreads effortlessly through the coughs and sneezes of an infected person. Once inhaled, the bacteria adhere to the ciliated epithelium in the nasopharynx, using surface proteins like filamentous hemagglutinin and pertactin to anchor themselves to the airway walls. They then multiply and secrete toxins that destroy the very mechanism the body uses to clear mucus and debris. Tracheal cytotoxin kills the ciliated cells, leaving the airways clogged and triggering the violent coughing that defines the disease. In infants, the bacteria can spread down to the lungs, causing pneumonia or encephalopathy, a brain condition resulting from oxygen deprivation. The bacterium is so specific to humans that it has no other natural host, though outbreaks have been observed in chimpanzees and gorillas in zoos, likely acquired through close contact with infected caretakers. The incubation period typically lasts seven to ten days, but can range from six to 42 days, allowing the disease to spread silently before the first symptoms appear.The Race For A Shield
The history of whooping cough prevention is a saga of scientific trial and error, spanning from the early 20th century to the present day. In 1912, Bordet and Gengou developed the first inactivated whole-cell vaccine, but it offered limited effectiveness. It was not until 1925 that Danish physician Thorvald Madsen tested a whole-cell vaccine on a wide scale, using it to control outbreaks in the Faroe Islands, though the tragedy of two children dying shortly after vaccination cast a long shadow over early efforts. The breakthrough came in 1932 when pediatrician Leila Denmark began studying an outbreak in Atlanta, Georgia, leading to the development of the first safe and effective pertussis vaccine in partnership with Emory University and Eli Lilly & Company. By 1942, American scientists Grace Eldering, Loney Gordon, and Pearl Kendrick combined the whole-cell pertussis vaccine with diphtheria and tetanus toxoids to create the first DTP combination vaccine. In 1981, Japanese scientist Yuji Sato introduced an acellular vaccine consisting of purified haemagglutinins, which reduced side effects and became the standard in many countries. Despite these advancements, immunity wanes over time, with protection lasting only three to six years after vaccination, leaving adolescents and adults as reservoirs for the bacteria and infecting vulnerable infants who have not yet received their full course of shots.